Posted in

The CT Advance Revolutionizing DBS Electrode Placement Accuracy

Accurate Deep Brain Stimulation (DBS) electrode placement is essential for successful neurological therapy. Consequently, precise DBS electrode localization remains a critical component of the entire workflow. Conventional Computed Tomography (CT) scans, routinely used postoperatively, often fail to delineate individual electrode contacts accurately due to severe metallic artifacts. This imaging limitation, called blooming, severely hinders optimal programming and decision-making. Researchers recently studied the efficacy of Extended Hounsfield Unit (EHU)-CT—an innovative imaging technique utilizing an expanded scale up to 40,000 HU—for improved visualization of these contacts.

EHU-CT vs. Conventional CT: The Critical Visualization Gap

The study, which included 58 DBS electrodes from 29 patients, compared conventional CT with EHU-CT reconstructions. Quantitative analysis showed near-perfect agreement between the two methods concerning overall electrode tip positioning (Intraclass Correlation Coefficient ≈ 1). Therefore, the overall electrode placement was consistent. Conversely, the qualitative assessment highlighted a stark difference in image interpretability. Specifically, EHU-CT enabled clear identification of all individual electrode contacts in 100% of the cases. Conventional CT, however, consistently failed to distinguish individual contacts because of pronounced blooming artifacts. Furthermore, localizations determined by conventional CT were notably sensitive to minor window-level adjustments, particularly along the z-axis, making reliable interpretation difficult. EHU-CT eliminates these issues by utilizing a wider Hounsfield scale, increasing the voxel value resolution of metallic structures.

Enhancing DBS Electrode Localization with EHU-CT

EHU-CT provides consistent, direct visualization of individual DBS contacts, establishing a robust alternative to conventional imaging. This direct visualization is vital for precision medicine. The technique’s reduced sensitivity to display settings and improved interpretability enhance the entire DBS workflow, from intra-operative confirmation to postoperative programming. Improved localization, especially when EHU-CT is co-registered with a pre-operative MRI, provides the anatomical context necessary for optimal therapeutic targeting. Consequently, clinicians gain increased confidence and efficiency when adjusting stimulation parameters, which ultimately supports better patient outcomes. Thus, EHU-CT represents a significant advance in the technical aspects of DBS therapy.

Frequently Asked Questions

Q1: What is the primary limitation of conventional CT for DBS follow-up?

The primary limitation is the metallic artifact, commonly known as the “blooming artifact.” This artifact causes the metallic electrode components to appear larger than their actual size, blurring the distinction between individual electrode contacts. This obscures the exact location of each contact, which is necessary for precise programming.

Q2: How does Extended Hounsfield Unit (EHU)-CT overcome the metal artifact?

EHU-CT expands the Hounsfield unit (HU) scale from the conventional range (up to ~4,000 HU) to a much wider range (up to 40,000 HU). This expanded scale provides better voxel value resolution for metallic materials, allowing the scanner to resolve the different radio-opacities of the individual metal components in the electrode array, effectively eliminating the blooming artifact.

References

  1. Kremer NI et al. Accurate localization of deep brain stimulation electrode contacts using extended Hounsfield unit computed tomography. Eur Radiol. 2025 Dec 20. doi: 10.1007/s00330-025-12179-8. PMID: 41420706.
  2. Hebb AO, Poliakov AV. Imaging of deep brain stimulation leads using extended Hounsfield unit CT. Stereotact Funct Neurosurg. 2009;87(3):155-60. doi: 10.1159/000209296.
  3. Choi H, Lee C, Kim J, et al. Metal Artifact Reduction in Head CT Performed for Patients with Deep Brain Stimulation Devices. AJNR Am J Neuroradiol. 2020;41(2):373-379. doi: 10.3174/ajnr.A6424.